Large-volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the Fenwal CS 3000 Plus from normal healthy donors: Predictors of CD34+ cell yield and collection efficiency

Journal of Clinical Apheresis

Volumn 18, Issue 1, 2003, Pages 10-15

  Sohn, Sang Kyun ^a   Kim, Jong Gwang ^a   Chae, Yeo Soo ^a   Kim, Dong Hwan ^a   Lee, Nan Young ^a   Suh, Jang Soo ^a   Lee, Kyu Bo ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Allogeneic; Apheresis; Femoral

Indexed keywords

CD34 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FEMORAL VEIN; HEMATOMA; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; LIVING DONOR; MALE; NORMAL HUMAN; PREDICTION; STEM CELL; VASCULAR ACCESS; VEIN CATHETERIZATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD34; BLOOD DONORS; CATHETERS, INDWELLING; FEMALE; FEMORAL VEIN; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0038077205     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.10044     Document Type: Article

References (26)

1. Kobbe G, Soehngen D, Heyll A, et al. Large volume leukapheresis maximizes the progenitor cell yield for allogeneic peripheral blood progenitor donation. J Hematother 1997;6:125-131.
2. Passos-Coelho JL, Machado MA, Lucio P, et al. Large-volume leukaphereses may be more efficient than standard-volume leukaphereses for collection of peripheral blood progenitor cells. J Hematother 1997;6:465-474.
3. Smolowicz AG, Villman K, Tidefelt U. Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion 1997;37:188-192.
4. Reik RA, Noto TA, Fernandez HF. Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells. J Clin Apheresis 1997;12:10-13.
5. Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, Ota DM. Complications and failures of subclavian-vein catheterization. N Engl J Med 1994;331:1735-1738.
6. Shariatmadar S, Noto TA. Femoral vascular access for largevolume collection of peripheral blood progenitor cells. J Clin Apheresis 1998;13:99-102.
7. Sohn SK, Jung JT, Kim DH, et al. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies. Cancer 2002;94:18-24.
8. Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-226.
9. Sohn SK, Kim JG, Seo KW, et al. Excellent mobilizing effect of a sequential combination regimen with GM-CSF followed by G-CSF in normal healthy donors for allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2002;30:81-86.
10. Stroncek DF, Clay ME, Petzoldt ML, et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 1996;36:601-610.
11. Bishop MR, Tarantolo SR, Jackson JD, et al. Allogeneicblood stem-cell collection following mobilization with lowdose granulocyte colony-stimulating factor. J Clin Oncol 1997;15:1601-1607.
12. Anderlini P, Korbling M, Dale D, et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood 1997;90:903-908.
13. Urbano-Ispizua A, Solano C, Brunet S, et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group. Bone Marrow Transplant 1996;18:35-40.
14. Malachowski ME, Comenzo RL, Hillyer CD, et al. Largevolume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 1992;32:732-735.
15. Hillyer CD, Tiegerman KO, Berkman EM. Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 1991;31:327-332.
16. Anderlini P, Przepiorka D, Seong C, et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997;37:507-512.
17. Luider J, Brown C, Selinger S, et al. Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresis. J Hematother 1997;6:575-580.
18. Ford CD, Lehman C, Strupp A, et al. Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwal CS 3000 Plus. J Clin Apheresis 2002;17:17-20.
19. de la Rubia J, Arbona C, de Arriba F, et al. Spanish Group of Allogeneic Peripheral Blood Stem Cell Transplantation. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002;42:4-9.
20. Rybka WB, Houshmand E, Mierski J, et al. Harvesting of GCSF mobilized donors for allogeneic peripheral blood stem cell transplantation [abstr]. Blood 1998;1117.
21. Armitage S, Hargreaves R, Samson D, et al. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997;20:587-591.
22. Schots R, Van Riet I, Damiaens S, et al. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509-515.
23. Benjamin RJ, Linsley L, Fountain D, et al. Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield. Transfusion 1997;37:79-85.
24. Diaz MA, Garcia-Sanchez F, Lillo R, et al. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield. Haematologica 1999;84:32-35.
25. Demirer T, Dagli M, Ilhan O, et al. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters. Bone Marrow Transplant 2002;29:893-897.
26. Schwarer AP, Messino NM, Gibson M, et al. A randomized trial of leukapheresis volumes, 7L versus 10L: an assessment of efficacy and patient tolerance. J Hematother Stem Cell Res 2000;9:269-274.